Invesco Portfolio holdings
Invesco is an investment management company that launched the Invesco QQQ exchange-traded fund in 1999, back when it operated as Amvescap. Invesco QQQ tracks the Nasdaq-100 index of companies listed on Nasdaq. Invesco traces its roots to H. Lotery & Co., a UK advisory firm formed in 1935, and in 1978 Charles Brady and eight partners bought the money management arm of Citizens & Southern National Bank, then called INVESCO. It bought PowerShares Capital Management, sponsor of 36 exchange-traded funds, in 2006, and in 2007 it went back to the Invesco name and moved its legal home to Bermuda. Its 2009 purchase of Morgan Stanley's retail unit brought in Van Kampen Investments, and in 2019 it acquired OppenheimerFunds from Massachusetts Mutual Life Insurance Company. It serves retail and institutional investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$6.35B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$2.84B |
| 3 |
Arm
ARM
|
+$1.84B |
| 4 |
Lumentum
LITE
|
+$1.78B |
| 5 |
Teradyne
TER
|
+$1.57B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2.26B |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.2B |
| 3 |
Honeywell
HON
|
+$2.2B |
| 4 |
Dell
DELL
|
+$1.69B |
| 5 |
Insmed
INSM
|
+$744M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.02% |
| 2 | Consumer Discretionary | 9.38% |
| 3 | Communication Services | 9.23% |
| 4 | Industrials | 8.59% |
| 5 | Healthcare | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2176
BlackRock Floating Rate Income Trust
BGT
$296M
| $5.41M | ﹤0.01% |
507,608
+57,607
| +13% | +$624K |
2013 Q2
52 quarters
|
|
|
DPC
2177
DPC Holdings PLC
DPC
$4.09B
| $5.4M | ﹤0.01% |
+110,000
| New | +$5.36M |
2026 Q2
0 quarters
|
|
2178
BlackRock Debt Strategies Fund
DSU
$560M
| $5.38M | ﹤0.01% |
554,585
-7,517
| -1% | -$73.6K |
2013 Q2
52 quarters
|
|
2179
On Holding
ONON
$11.3B
| $5.37M | ﹤0.01% |
151,490
-4,226
| -3% | -$154K |
2022 Q3
15 quarters
|
|
2180
CONMED
CNMD
$1.32B
| $5.36M | ﹤0.01% |
163,732
-2,908
| -2% | -$105K |
2013 Q2
52 quarters
|
|
2181
Iovance Biotherapeutics
IOVA
$3.84B
| $5.35M | ﹤0.01% |
1,285,176
-137,141
| -10% | -$521K |
2019 Q4
26 quarters
|
|
2182
Heartland Express
HTLD
$790M
| $5.33M | ﹤0.01% |
350,290
-74,594
| -18% | -$1.01M |
2013 Q2
52 quarters
|
|
2183
Shake Shack
SHAK
$2.85B
| $5.31M | ﹤0.01% |
94,836
+16,433
| +21% | +$1.24M |
2017 Q1
37 quarters
|
|
2184
Allspring Global Dividend Opportunity Fund
EOD
$267M
| $5.31M | ﹤0.01% |
812,462
-54,313
| -6% | -$348K |
2024 Q1
9 quarters
|
|
|
FCT
2185
DELISTED
First Trust Senior Floating Rate Income Fund II
FCT
| $5.3M | ﹤0.01% |
548,313
-16,234
| -3% | -$157K |
2013 Q2
52 quarters
|
|
2186
Under Armour Class C
UA
$2.08B
| $5.29M | ﹤0.01% |
850,750
+89,990
| +12% | +$518K |
2016 Q2
40 quarters
|
|
2187
KE Holdings
BEKE
$19.4B
| $5.29M | ﹤0.01% |
364,107
-69,995
| -16% | -$1.15M |
2020 Q3
23 quarters
|
|
2188
PIMCO Income Strategy Fund II
PFN
$615M
| $5.29M | ﹤0.01% |
741,884
+49,566
| +7% | +$345K |
2013 Q2
52 quarters
|
|
2189
CNA Financial
CNA
$13.2B
| $5.23M | ﹤0.01% |
107,634
+19,948
| +23% | +$908K |
2013 Q2
52 quarters
|
|
2190
DELISTED
Apogee Therapeutics
APGE
| $5.22M | ﹤0.01% |
39,317
+554
| +1% | +$49.9K |
2023 Q3
11 quarters
|
|
2191
Frequency Electronics
FEIM
$763M
| $5.19M | ﹤0.01% |
+78,270
| New | +$4.82M |
2026 Q2
0 quarters
|
|
2192
Scholar Rock
SRRK
$5.35B
| $5.18M | ﹤0.01% |
94,156
-25,441
| -21% | -$1.23M |
2023 Q1
13 quarters
|
|
2193
ZoomInfo Technologies
GTM
$1.27B
| $5.16M | ﹤0.01% |
1,761,510
+340,378
| +24% | +$1.53M |
2020 Q2
24 quarters
|
|
2194
Azenta
AZTA
$1.71B
| $5.16M | ﹤0.01% |
202,203
-10,861
| -5% | -$243K |
2013 Q2
52 quarters
|
|
2195
Howard Hughes
HHH
$4.55B
| $5.15M | ﹤0.01% |
71,984
-1,556
| -2% | -$101K |
2013 Q2
52 quarters
|
|
2196
Palvella Therapeutics
PVLA
$2.11B
| $5.14M | ﹤0.01% |
33,652
-14,875
| -31% | -$1.81M |
2025 Q3
3 quarters
|
|
2197
Triumph Financial Inc
TFIN
$1.49B
| $5.07M | ﹤0.01% |
66,480
-5,322
| -7% | -$362K |
2015 Q2
44 quarters
|
|
2198
DELISTED
Avanos Medical
AVNS
| $5.07M | ﹤0.01% |
203,811
-7,243
| -3% | -$170K |
2014 Q4
46 quarters
|
|
2199
Universal Technical Institute
UTI
$1.25B
| $5.06M | ﹤0.01% |
118,198
+59,077
| +100% | +$2.27M |
2022 Q2
16 quarters
|
|
2200
Allspring Multi-Sector Income Fund
ERC
$238M
| $5.02M | ﹤0.01% |
545,530
+1,651
| +0.3% | +$15K |
2013 Q2
52 quarters
|
|
Similar funds
Invesco's Q2 2026 Portfolio in Review
As of Q2 2026, Invesco held 3,969 positions worth $1.26T, up 23% from $1.02T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Invesco's Q2 2026 filing shows 214 new, 1,806 increased, 1,705 reduced and 150 closed positions. Its largest new stake was Honeywell Aerospace: 12,884,435 shares worth $2.85B. The largest sale was Invesco NASDAQ 100 ETF, an estimated $2.26B.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Invesco's largest Q2 2026 buy was Honeywell Aerospace: 12,884,435 shares worth $2.85B.
- Invesco added most to Sandisk in Q2 2026, an estimated $6.35B increase.
- Invesco's biggest Q2 2026 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $2.26B.
- Invesco fully exited Coterra Energy in Q2 2026, selling an estimated $394M.
- Invesco's ten largest holdings make up 29% of its $1.26T portfolio in Q2 2026.
- Invesco opened 214 new positions and closed 150 in Q2 2026.
- Invesco's portfolio value rose 23% quarter-over-quarter to $1.26T.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.